leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 21:27:10 - browse：35494

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Medtronic CEO on promising devices for diabetes, hypertension

WSS

Testing for cancer recurrence creates a new limbo for patients

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Traditional Chinese medicine benefits explored in new JAMA study

Traditional Chinese medicine benefits explored in new JAMA study

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

focus

leisure time

hotspot

Affirmative action in medical school literally saved lives

CDC recommends rationing of RSV shot due to shortages

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

As demand for Covid shots wanes, Moderna seeks its next success

Community Health Systems hospitals under DOJ investigation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A new nitrogen execution bill also undermines medical licensing

As demand for Covid shots wanes, Moderna seeks its next success

The pink breast cancer awareness ribbon needs a redesign

focus

Senate panel to vote on hospitals, PBMs, prisoner care

WHO may add ‘noma' to its list of neglected tropical diseases

The pink breast cancer awareness ribbon needs a redesign

A new nitrogen execution bill also undermines medical licensing

In utero gene editing: an explainer

The FDA weighs the risks of candy

explore

focus

Wikipedia

leisure time